Karthik Dhananjayan, Ph.D.
Affiliations: | 2015-2019 | Department of Pharmacology, School of Medicine | Western Sydney University |
2019- | Department of Pharmacology | PSG College of Pharmacy |
Area:
Neuroinflammation, Neurodegeneration, Cognitive neuroscienceGoogle:
"Karthik Dhananjayan"Mean distance: (not calculated yet)
Parents
Sign in to add mentorGerald Muench | grad student | 2015-2019 | School of Medicine, Western Sydney University |
Children
Sign in to add traineeUmamaheswari Arunachalam | grad student | 2018-2020 | PSG College of Pharmacy |
Dinakar Subramanian | grad student | 2018-2020 | PSG College of Pharmacy |
Thilagavathi Dayananda Chandrasekaran | grad student | 2019-2021 | PSG College of Pharmacy |
Gurubarath Mani | grad student | 2019-2021 | PSG College of Pharmacy |
Dhinesh Kumar Venkatesh | grad student | 2019-2021 | PSG College of Pharmacy |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dhananjayan K, Irrgang F, Ritesh R, et al. (2019) Determination of glyoxal and methylglyoxal in serum by UHPLC coupled with fluorescence detection. Analytical Biochemistry. 573: 51–66 |
Gyengesi E, Liang H, Millington C, et al. (2018) Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice. Pharmaceutical Research. 35: 22 |
Dhananjayan K, Forbes J, Munch G. (2018) Advanced Glycation, Diabetes, and Dementia Type 2 Diabetes and Dementia. 169-193 |
Dhananjayan K, Gunawardena D, Hearn N, et al. (2017) Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus? Journal of Alzheimer's Disease : Jad |
Dhananjayan K, Arunachalam S, Sivanandy P, et al. (2015) Computational drug discovery of Rho – associated coiled coil kinase II (ROCK-II) inhibitors as a target for neurodegenerative disorders – an insilico docking studies. Orient Pharm Exp Med. 15: 53–71 |
Dhananjayan K. (2015) Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1) Journal of Cancer Research. 2015: 1-15 |
Dhananjayan K, Arunachalam S, Sivanandy P, et al. (2015) Computational drug discovery of Rho – associated coiled coil kinase II (ROCK-II) inhibitors as a target for neurodegenerative disorders – an insilico docking studies Oriental Pharmacy and Experimental Medicine. 15: 53-71 |